{"abstract": "The advent of a challenger has the potential to expand sales of drugs to treat blood clots in veins.", "web_url": "https://www.nytimes.com/2009/03/20/business/20drug.html", "snippet": "The advent of a challenger has the potential to expand sales of drugs to treat blood clots in veins.", "lead_paragraph": "For decades, an anticlotting drug called warfarin has dominated the market for oral medications used to treat blood clots that form in the veins. Now, there may finally be a new contender.", "print_section": "B", "print_page": "8", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Panel Gives Nod to Alternative to Warfarin", "kicker": null, "content_kicker": null, "print_headline": "Panel Votes to Recommend Anticlotting Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Blood Clots", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Bayer AG", "rank": 4, "major": "N"}], "pub_date": "2009-03-20T01:06:43+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/65458d8e-3773-5256-81cb-fc2d35d3208b", "word_count": 576, "uri": "nyt://article/65458d8e-3773-5256-81cb-fc2d35d3208b"}